Colesevelam + Colesevelam matching placebo + Insulin glargine (Lantus)
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes
Conditions
Type 2 Diabetes
Trial Timeline
Jun 1, 2005 → Jan 1, 2008
NCT ID
NCT00147745About Colesevelam + Colesevelam matching placebo + Insulin glargine (Lantus)
Colesevelam + Colesevelam matching placebo + Insulin glargine (Lantus) is a phase 2 stage product being developed by Daiichi Sankyo for Type 2 Diabetes. The current trial status is completed. This product is registered under clinical trial identifier NCT00147745. Target conditions include Type 2 Diabetes.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00147745 | Phase 2 | Completed |
Competing Products
20 competing products in Type 2 Diabetes